|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| CERT | SMITH PATRICK F | Officer | Apr 02 '25 | Proposed Sale | 9.73 | 20,142 | 195,982 | Apr 02 10:57 AM | |
| CERT | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Oct 07 '24 | Sale | 11.03 | 5,409 | 59,661 | 50,091 | Oct 08 04:17 PM |
| CERT | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Oct 04 '24 | Option Exercise | 0.00 | 7,151 | 0 | 57,242 | Oct 07 04:42 PM |
| CERT | SMITH PATRICK F | Officer | Oct 07 '24 | Proposed Sale | 11.03 | 5,409 | 59,661 | Oct 07 09:48 AM | |
| CERT | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Apr 02 '24 | Sale | 16.85 | 14,427 | 243,161 | 50,091 | Apr 04 04:45 PM |
| CERT | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Apr 01 '24 | Option Exercise | 0.00 | 16,498 | 0 | 67,208 | Apr 03 05:07 PM |
| CERT | SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTIONS | Feb 20 '24 | Sale | 18.00 | 5,000 | 90,000 | 54,975 | Feb 21 04:40 PM |
| CERT | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | Jun 05 '23 | Sale | 21.55 | 19,104 | 411,691 | 59,975 | Jun 06 04:56 PM |
| CERT | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | Mar 31 '23 | Option Exercise | 0.00 | 8,646 | 0 | 81,973 | Apr 03 04:51 PM |
| CERT | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | Nov 09 '22 | Sale | 13.48 | 2,387 | 32,177 | 74,859 | Nov 14 04:33 PM |
| CERT | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | Aug 16 '22 | Sale | 17.71 | 10,000 | 177,100 | 78,490 | Aug 18 05:12 PM |
| CERT | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | Jun 08 '22 | Sale | 19.16 | 10,000 | 191,600 | 88,490 | Jun 09 04:44 PM |
| CERT | SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | Apr 04 '22 | Sale | 22.29 | 3,352 | 74,716 | 98,490 | Apr 05 04:26 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite